These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3006422)
1. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas. Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422 [TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age. Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083 [TBL] [Abstract][Full Text] [Related]
3. Chromosome number and carmustine sensitivity in human gliomas. Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658 [TBL] [Abstract][Full Text] [Related]
4. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
5. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT; Siemann DW Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329 [TBL] [Abstract][Full Text] [Related]
6. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). Weiss RB; Issell BF Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924 [No Abstract] [Full Text] [Related]
7. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771 [TBL] [Abstract][Full Text] [Related]
8. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834 [TBL] [Abstract][Full Text] [Related]
9. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas. Brajtburg J; Elberg S; Schechtman KB; Medoff G Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154 [TBL] [Abstract][Full Text] [Related]
11. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of rats. Deen DF; Williams ME; Wheeler KT Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1541-4. PubMed ID: 536259 [No Abstract] [Full Text] [Related]
13. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486 [TBL] [Abstract][Full Text] [Related]
14. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU. Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602 [TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks. Batista LF; Roos WP; Christmann M; Menck CF; Kaina B Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819 [TBL] [Abstract][Full Text] [Related]
16. Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas. Brajtburg J; Elberg S; Kobayashi GS; Medoff G Antimicrob Agents Chemother; 1988 Mar; 32(3):327-30. PubMed ID: 3284460 [TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621 [TBL] [Abstract][Full Text] [Related]
18. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells. Wong KH; Wallen CA; Wheeler KT J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513 [TBL] [Abstract][Full Text] [Related]
19. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole. Wheeler KT; Wallen CA; Wolf KL; Siemann DW Br J Cancer; 1984 Jun; 49(6):787-93. PubMed ID: 6733024 [TBL] [Abstract][Full Text] [Related]